PT  - JOURNAL ARTICLE
AU  - dos Santos, Mirleide Cordeiro
AU  - Sousa, Edivaldo Costa
AU  - de Almeida Ferreira, Jessylene
AU  - da Silva, Sandro Patroca
AU  - de Souza, Michel Platini Caldas
AU  - Cardoso, Jedson Ferreira
AU  - Silva, Amanda Mendes
AU  - Barbagelata, Luana Soares
AU  - Chagas, Wanderley Dias das
AU  - Ferreira, James Lima
AU  - de Souza, Edna Maria Acunã
AU  - Vilaça, Patrícia Louise Araújo
AU  - dos Santos Alves, Jainara Cristina
AU  - de Abreu, Michelle Carvalho
AU  - dos Santos Lobo, Patrícia
AU  - da Silva dos Santos, Fabíolla
AU  - Lima, Alessandra Alves Polaro
AU  - de Marco Bragagnolo, Camila
AU  - da Silva Soares, Luana
AU  - de Almeida, Patricía Sousa Moraes
AU  - de Souza Oliveira, Darleise
AU  - Amorim, Carolina Koury Nassar
AU  - Costa, Iran Barros
AU  - Teixeira, Dielle Monteiro
AU  - da Penha, Edvaldo Tavares
AU  - Bezerra, Delana Andreza Melo
AU  - Siqueira, Jones Anderson Monteiro
AU  - Tavares, Fernando Neto
AU  - Freitas, Felipe Bonfim
AU  - Rodrigues, Janete Taynã Nascimento
AU  - Mazaro, Janaína
AU  - Costa, Andreia Santos
AU  - Cavalcante, Márcia Socorro Pereira
AU  - da Silva, Marineide Souza
AU  - Araújo, Guilherme Alfredo Novelino
AU  - da Silva, Ilvanete Almeida
AU  - Borges, Gleissy Adriane Lima
AU  - de Lima, Lídio Gonçalves
AU  - dos Santos Ferreira, Hivylla Lorrana
AU  - Livorati, Miriam Teresinha Furlam Prando
AU  - de Abreu, André Luiz
AU  - de Medeiros, Arnaldo Correia
AU  - Resque, Hugo Reis
AU  - Sousa, Rita Catarina Medeiros
AU  - Viana, Giselle Maria Rachid
TI  - MOLECULAR EPIDEMIOLOGY TO UNDERSTAND THE SARS-CoV-2 EMERGENCE IN THE BRAZILIAN AMAZON REGION
AID  - 10.1101/2020.09.04.20184523
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.09.04.20184523
4099  - http://medrxiv.org/content/early/2020/09/07/2020.09.04.20184523.short
4100  - http://medrxiv.org/content/early/2020/09/07/2020.09.04.20184523.full
AB  - The COVID-19 pandemic in Brazil has demonstrated an important public health impact, as has been observed in the world. In Brazil, the Amazon Region contributed with a large number of cases of COVID-19, especially in the beginning of the circulation of SARS-CoV-2 in the country. Thus, we describe the epidemiological profile of COVID-19 and the genetic diversity of SARS-CoV-2 strains circulating in the Amazon Region. We observe an extensive spread of virus in this Brazilian site. The data on sex, age and symptoms presented by the investigated individuals were similar to what has been observed worldwide. The genomic analysis of the viruses revealed important amino acid changes, including the D614G and the I33T in Spike and ORF6 proteins, respectively. The latter found in strains originating in Brazil. The phylogenetic analyzes demonstrated the circulation of the lineages B.1 and B.1.1, whose circulation in Brazil has already been previous reported. Our data reveals molecular epidemiology of SARS-CoV-2 in the Amazon Region. These findings also reinforce the importance of continuous genomic surveillance this virus with the aim of providing accurate and updated data to understand and map the transmission network of this agent in order to subsidize operational decisions in public health.Competing Interest StatementThe authors have declared no competing interest.Funding StatementMinistry of HealthAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by Evandro Chagas Institute Ethical Committee with CAAE:34931820.0.0000.0019All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available on GISAID